TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33784761

Group type: EXPERIMENTAL
Intervention: Closure of parietal peritoneum and reapproximation of rectus muscle (group 3)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Closure of parietal peritoneum only (group 2)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Both parietal peritoneum and rectus abdominis muscle left open (group 1)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Meperidine requirements
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Return of bowel motility
Number of subjects: 180
Study: 32332289

Group type: EXPERIMENTAL
Intervention: Surgical patients ages 0-<2
Number of subjects: 175878

Group type: EXPERIMENTAL
Intervention: Surgical patients ages 2-<6
Number of subjects: 175878

Group type: EXPERIMENTAL
Intervention: Surgical patients ages 6-<12
Number of subjects: 175878

Group type: EXPERIMENTAL
Intervention: Surgical patients ages 12-18
Number of subjects: 175878

Group type: EXPERIMENTAL
Intervention: All age groups of surgical patients
Number of subjects: 175878

Group type: COMPARATOR
Intervention: Nonsurgical patients
Number of subjects: 175878
Study: 33395734

Group type: EXPERIMENTAL
Intervention: Treatment Group 2 (n=18) received a booklet, a tailored care plan, and four coaching sessions
Number of subjects: 25

Group type: COMPARATOR
Intervention: Treatment Group 1 (n=7) received an educational booklet
Number of subjects: 25
Study: 33285517

Group type: EXPERIMENTAL
Intervention: Advance Care Planning (ACP) intervention facilitating accurate prognostic awareness (PA)
Number of subjects: 460

Group type: COMPARATOR
Intervention: Control arm (symptom-management education)
Number of subjects: 460
Study: 35050957

Group type: EXPERIMENTAL
Intervention: Inhaled nitrous oxide/oxygen (N2O/O2) 50%-50% equimolar mixture (EMONO)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 32964918

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 21 g (300 mg/kg) for 20 hours
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo (dextrose 5%)
Number of subjects: 135
Study: 32745306

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy for 5 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Hyperbaric oxygen therapy for 3 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen responders
Number of subjects: 20
Study: 35930329

Group type: EXPERIMENTAL
Intervention: Fact-focused conversation (prompted about objective event elements)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Emotion-focused conversation (prompted about subjective reactions to the event)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Emotion-focused conversation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Fact-focused conversation
Number of subjects: 100
Study: 32298202

Group type: EXPERIMENTAL
Intervention: CART-19 (high dose 5 × 10^8)
Number of subjects: 42

Group type: COMPARATOR
Intervention: CART-19 (low dose 5 × 10^7)
Number of subjects: 42
Study: 35144958

Group type: EXPERIMENTAL
Intervention: IMPACT intervention (mHealth application, symptom watch, tailored health intervention) for 8 weeks with weekly activities including symptom monitoring, goal setting, and progress monitoring.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 60
Study: 33765633

Group type: EXPERIMENTAL
Intervention: Isokinetic strengthening (4 weeks, 3 days/week)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Isokinetic strengthening
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (tailored strengthening exercises with exercise bands)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 33433041

Group type: EXPERIMENTAL
Intervention: NB-UVB phototherapy plus 480 mg oral Polypodium leucotomos (PL) twice daily
Number of subjects: 44

Group type: COMPARATOR
Intervention: NB-UVB phototherapy plus placebo
Number of subjects: 44
Study: 34128884

Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency (PRF) at 42°C for 120 seconds plus oral alpha lipoic acid (ALA) 600 mg three times per day for 3 weeks then 600 mg once daily for 2 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pulsed radiofrequency (PRF) at 42°C for 120 seconds
Number of subjects: 120
Study: 32844300

Group type: EXPERIMENTAL
Intervention: Low-fidelity inguinal canal model
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (no model)
Number of subjects: 106
Study: 36328157

Group type: EXPERIMENTAL
Intervention: Edoxaban (once daily for 3 months)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Standard of Care (SOC) anticoagulation (low molecular weight heparins or vitamin K antagonists)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Edoxaban (extension arm for 1 year)
Number of subjects: 167
Study: 32682552

Group type: EXPERIMENTAL
Intervention: PEEP5 (5 cm H2O)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: PEEP8 (8 cm H2O)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: PEEP12 (12 cm H2O)
Number of subjects: 47
Study: 34800474

Group type: EXPERIMENTAL
Intervention: Mailed HPV self-sampling kits
Number of subjects: 16590

Group type: EXPERIMENTAL
Intervention: Completed cervical cancer screening (Pap)
Number of subjects: 16590
Study: 33009645

Group type: EXPERIMENTAL
Intervention: PVI+PWI using cryoballoon
Number of subjects: 366

Group type: COMPARATOR
Intervention: PVI using cryoballoon
Number of subjects: 366
Study: 34763370

Group type: EXPERIMENTAL
Intervention: Vocal music listening
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Instrumental music listening
Number of subjects: 38

Group type: COMPARATOR
Intervention: Audio books
Number of subjects: 38
Study: 33615173

Group type: EXPERIMENTAL
Intervention: CIGB-325 (2.5 mg/kg/day during 5 consecutive days) plus standard-of-care
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard-of-care alone
Number of subjects: 20
Study: 34062308

Group type: EXPERIMENTAL
Intervention: IUI with letrozole
Number of subjects: 100

Group type: COMPARATOR
Intervention: Natural cycle IUI
Number of subjects: 100
Study: 34082177

Group type: EXPERIMENTAL
Intervention: 200 mg/kg natural oregano essential oil (NOEO)
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: 200 mg/kg synthetic oregano essential oil (SOEO)
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: 20 mg/kg colistin sulfate and 20 mg/kg virginiamycin (antibiotics)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Control diet (antibiotic-free)
Number of subjects: 384
Study: 35505379

Group type: EXPERIMENTAL
Intervention: Interactive pictorial health education program
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine community lecture health education
Number of subjects: 120
Study: 32799723

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 160

Group type: COMPARATOR
Intervention: Coffee consumption (provided three times a day)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Chewing sugar-free gum (for 15 min with an interval of 4 h from the second postoperative hour)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 160
Study: 35872223

Group type: EXPERIMENTAL
Intervention: Automated segmentation using a deep convolutional neural network (CNN) model
Number of subjects: 144

Group type: COMPARATOR
Intervention: Manual segmentation
Number of subjects: 144
Study: 32081599

Group type: EXPERIMENTAL
Intervention: Memantine (5 mg/d)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg/d)
Number of subjects: 40
Study: 35209851

Group type: EXPERIMENTAL
Intervention: New IMT/PEP device
Number of subjects: 80

Group type: COMPARATOR
Intervention: Threshold IMT device
Number of subjects: 80
Study: 33217836

Group type: EXPERIMENTAL
Intervention: Modified Xiaoyao Powder (MXP)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280
Study: 35564356

Group type: EXPERIMENTAL
Intervention: NANO restoration with metal matrix (NANO-METAL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: NANO restoration with transparent matrix (NANO-TRANS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: BFC restoration with metal matrix (BFC-METAL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: BFC restoration with transparent matrix (BFC-TRANS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: NANO restoration
Number of subjects: 40
Study: 34003726

Group type: EXPERIMENTAL
Intervention: A Program of SUPPORT
Number of subjects: 76

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 76
Study: 32282773

Group type: EXPERIMENTAL
Intervention: Nonaggressive hydration (Hartmann's solution at 1.5 mL kg h for the first 24 hours and 30 mL kg during the next 24 hours)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Aggressive hydration (bolus of Hartmann's solution 20 mL kg, followed by an infusion of 3 mL kg h for the first 24 hours and then 30 mL kg for the next 24 hours)
Number of subjects: 88
Study: 36273180

Group type: EXPERIMENTAL
Intervention: Emotionally Focused Therapy (EFT) for couples, 19-21 sessions
Number of subjects: 140

Group type: COMPARATOR
Intervention: Waitlist control group receiving psycho-educational program based on EFT after the study
Number of subjects: 140
Study: 33575950

Group type: EXPERIMENTAL
Intervention: IR‐ESO (esomeprazole 20 mg and sodium bicarbonate 1100 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: ESO (esomeprazole delayed release tablet 20 mg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: IR‐ESO and ESO
Number of subjects: 40
Study: 34356647

Group type: EXPERIMENTAL
Intervention: Synthetic abdominal swabs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cotton abdominal swabs
Number of subjects: 0
Study: 32006325

Group type: EXPERIMENTAL
Intervention: Polyethylene glycolated exenatide injection (PB-119) at doses of 2-200 µg
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Polyethylene glycolated exenatide injection (PB-119) at doses of 25-400 µg
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 616996472

Group type: EXPERIMENTAL
Intervention: Pridopidine 45 mg twice daily
Number of subjects: 22

Group type: COMPARATOR
Intervention: Metoprolol 100 mg alone
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Pridopidine 90 mg single dose
Number of subjects: 22
Study: 32063079

Group type: EXPERIMENTAL
Intervention: Combined intralesional triamcinolone acetonide (TA) and platelet rich plasma (PRP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intralesional triamcinolone acetonide (TA) alone
Number of subjects: 40
Study: 34724955

Group type: EXPERIMENTAL
Intervention: Goal Management Training (pGMT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Psychoeducative control (paediatric Brain Health Workshop, pBHW)
Number of subjects: 76
Study: 35553192

Group type: EXPERIMENTAL
Intervention: tVNSab (transcutaneous vagal nerve stimulation applied to the auricle branch of the vagus nerve)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: tVNSab
Number of subjects: 7
Study: 33851905

Group type: EXPERIMENTAL
Intervention: Preoperative opioid counseling (5-minute pre-recorded standardized video)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 107
Study: 36081136

Group type: EXPERIMENTAL
Intervention: Visual stimuli program during soccer training
Number of subjects: 38

Group type: COMPARATOR
Intervention: Regular soccer training program alone
Number of subjects: 38
Study: 32434381

Group type: EXPERIMENTAL
Intervention: BioFreedom stent
Number of subjects: 3151

Group type: COMPARATOR
Intervention: Orsiro stent
Number of subjects: 3151
Study: 33657754

Group type: EXPERIMENTAL
Intervention: MST to non-paralytic dorsiflexion muscles (n=11)
Number of subjects: 21

Group type: COMPARATOR
Intervention: MST to paralytic dorsiflexion muscles (n=10)
Number of subjects: 21
Study: 34902050

Group type: EXPERIMENTAL
Intervention: High GI rice (GI: 79)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Medium GI rice (GI: 64)
Number of subjects: 212
Study: 33165774

Group type: EXPERIMENTAL
Intervention: GSK2982772 120 mg TID for 1 day
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: GSK2982772 240 mg TID for 1 day
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: GSK2982772 120 mg TID for 14 days
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: GSK2982772 240 mg TID for 14 days
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo TID for 1 day
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo TID for 14 days
Number of subjects: 28
Study: 32014029

Group type: EXPERIMENTAL
Intervention: Doll Therapy Intervention
Number of subjects: 128

Group type: COMPARATOR
Intervention: Sham Intervention
Number of subjects: 128
Study: 33942506

Group type: EXPERIMENTAL
Intervention: Autologous heterogeneous skin construct
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard-of-care treatment
Number of subjects: 50
Study: 33631359

Group type: EXPERIMENTAL
Intervention: WL + weighted vest use (WL + VEST)
Number of subjects: 192

Group type: COMPARATOR
Intervention: WL alone
Number of subjects: 192

Group type: COMPARATOR
Intervention: WL + RT
Number of subjects: 192
Study: 36441560

Group type: EXPERIMENTAL
Intervention: Etripamil 70 mg
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 33140199

Group type: EXPERIMENTAL
Intervention: Adrenomedullin (AM) at 15 ng/kg/min
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 35101082

Group type: EXPERIMENTAL
Intervention: Community dialogue approach
Number of subjects: 0
Study: 32894122

Group type: EXPERIMENTAL
Intervention: Free healthy school meal for one year
Number of subjects: 164
Study: 35489024

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 256

Group type: COMPARATOR
Intervention: Control (chemotherapy without bevacizumab)
Number of subjects: 256
Study: 34743721

Group type: EXPERIMENTAL
Intervention: WW (formerly Weight Watchers) for 12‐weeks
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: WW (formerly Weight Watchers) for 52‐weeks
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: WW mobile app
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: Study visits at 3‐, 12‐, 24‐, and 60‐months
Number of subjects: 1267
Study: 35443365

Group type: EXPERIMENTAL
Intervention: Diabetes self-management education (DSME) program
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no DSME)
Number of subjects: 120
Study: 34530286

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the right auditory cortex
Number of subjects: 41

Group type: COMPARATOR
Intervention: Sham tDCS over the right auditory cortex
Number of subjects: 41
Study: 32573284

Group type: EXPERIMENTAL
Intervention: Tailored physiotherapy intervention
Number of subjects: 42
Study: 33743851

Group type: EXPERIMENTAL
Intervention: Olaparib (300 mg in two 150 mg tablets twice daily)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Olaparib
Number of subjects: 295
Study: 34710550

Group type: EXPERIMENTAL
Intervention: Mechanical Active Compression-Decompression CPR (ACD-CPR)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Complete AD in > 50% of OUs
Number of subjects: 210

Group type: COMPARATOR
Intervention: Standard Mechanical CPR (Control)
Number of subjects: 210
Study: 33237565

Group type: EXPERIMENTAL
Intervention: Otago exercise program
Number of subjects: 72

Group type: COMPARATOR
Intervention: Walking program (control)
Number of subjects: 72
Study: 35538754

Group type: EXPERIMENTAL
Intervention: Recombinant bovine basic fibroblast growth factor gel
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (Erythromycin ointment)
Number of subjects: 120
Study: 33238898

Group type: EXPERIMENTAL
Intervention: Continuous care (CC) by trained maternity care assistants (MCAs) during labor
Number of subjects: 992

Group type: COMPARATOR
Intervention: Care-as-usual (CAU)
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: Continuous care (CC)
Number of subjects: 992
Study: 35412513

Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP)
Number of subjects: 210

Group type: COMPARATOR
Intervention: No-pill control (NPC)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Double-blind placebo (DBP)
Number of subjects: 210
Study: 32232943

Group type: EXPERIMENTAL
Intervention: Wireless spinal cord stimulation (SCS) system
Number of subjects: 12
Study: 32646565

Group type: EXPERIMENTAL
Intervention: Post-discharge bleeding events (GUSTO moderate, severe, or life-threatening bleeding)
Number of subjects: 45011

Group type: EXPERIMENTAL
Intervention: Post-discharge myocardial infarction (MI)
Number of subjects: 45011

Group type: COMPARATOR
Intervention: Participants treated with PCI
Number of subjects: 45011

Group type: COMPARATOR
Intervention: Participants treated without PCI
Number of subjects: 45011
Study: 33417699

Group type: EXPERIMENTAL
Intervention: Hierarchical Bayesian model for drug response in cancer cell lines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conditional randomization testing procedure
Number of subjects: 0
Study: 34492709

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (6-month, thrice weekly, moderate-vigorous intensity cycling)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stretching (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention
Number of subjects: 0
Study: 32209015

Group type: EXPERIMENTAL
Intervention: MenACYW-TT (n = 403)
Number of subjects: 810

Group type: COMPARATOR
Intervention: MCV4-DT (Menactra®) (n = 407)
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: MenACYW-TT and MCV4-DT
Number of subjects: 810
Study: 35317764

Group type: EXPERIMENTAL
Intervention: eHealth patient education tool
Number of subjects: 216

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 216
Study: 33050952

Group type: EXPERIMENTAL
Intervention: Specific Emotional‐Cognitive Therapy (SECT)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Emotion‐Focused Supportive Therapy (EFST)
Number of subjects: 300
Study: 34534489

Group type: EXPERIMENTAL
Intervention: Second BCG vaccination
Number of subjects: 47000
Study: 32738573

Group type: EXPERIMENTAL
Intervention: Probiotic capsule (PC)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control capsule (CC)
Number of subjects: 35
Study: 35296055

Group type: EXPERIMENTAL
Intervention: Personalized computerized cognitive stimulation program, 8 weeks, training 5 days per week
Number of subjects: 60

Group type: COMPARATOR
Intervention: Orthogonal activities (active control group)
Number of subjects: 60
Study: 32115671

Group type: EXPERIMENTAL
Intervention: Ultrasound multimodal score in the AA group
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 138
Study: 35642463

Group type: EXPERIMENTAL
Intervention: Gla + 2-3 OADs
Number of subjects: 384

Group type: COMPARATOR
Intervention: Asp30 + MET
Number of subjects: 384
Study: 35355062

Group type: EXPERIMENTAL
Intervention: Preimplantation genetic testing for aneuploidy (PGT-A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-use of preimplantation genetic testing for aneuploidy (PGT-A)
Number of subjects: 0
Study: 34465356

Group type: EXPERIMENTAL
Intervention: Robot-aided rehabilitation (experimental group, n = 10)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Traditional rehabilitative protocol (control group, n = 13)
Number of subjects: 23
Study: 34898136

Group type: EXPERIMENTAL
Intervention: Vestibular nerve stimulation for 90 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham stimulation for 90 days
Number of subjects: 30
Study: 33538178

Group type: EXPERIMENTAL
Intervention: Thymosin α1
Number of subjects: 0
Study: 32345294

Group type: EXPERIMENTAL
Intervention: High social capital
Number of subjects: 536

Group type: COMPARATOR
Intervention: Low social capital
Number of subjects: 536
Study: 33999371

Group type: EXPERIMENTAL
Intervention: High levels of parathyroid hormone (PTH) in patients with positive histology for hepatic fibrosis, steatosis, and NASH/NAFLD
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High levels of PTH in patients with liver fibrosis confirmed by elastography
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Correlation of PTH with hepatic fibrosis, NASH, and steatosis
Number of subjects: 90
Study: 34154353

Group type: EXPERIMENTAL
Intervention: ICF concept rehabilitation training
Number of subjects: 142

Group type: COMPARATOR
Intervention: Routine rehabilitation training (Control)
Number of subjects: 142
Study: 32715961

Group type: EXPERIMENTAL
Intervention: Metastatic ovarian cancer patients
Number of subjects: 2991

Group type: COMPARATOR
Intervention: Matched controls without cancer
Number of subjects: 2991
Study: 33427425

Group type: EXPERIMENTAL
Intervention: Prepuncture flow-mediated dilation (FMD [+])
Number of subjects: 222

Group type: COMPARATOR
Intervention: No prepuncture flow-mediated dilation (FMD [-])
Number of subjects: 222
Study: 32862256

Group type: EXPERIMENTAL
Intervention: Iodine tampon
Number of subjects: 87

Group type: COMPARATOR
Intervention: Monoject® syringe
Number of subjects: 87
Study: 35780390

Group type: EXPERIMENTAL
Intervention: Intermittent Pneumatic Compression (IPC)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Neuromuscular Electrical Stimulation (NMES)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control sessions (no interventions)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Bioimpedance measurements across oedematous tissue
Number of subjects: 6
Study: 36417812

Group type: EXPERIMENTAL
Intervention: Semi-immersive virtual reality (VR) training, 3 times a week for 8 weeks.
Number of subjects: 106

Group type: COMPARATOR
Intervention: Traditional therapy (Control group).
Number of subjects: 106
Study: 33403549

Group type: EXPERIMENTAL
Intervention: High flow nasal oxygen (HFNO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional nasal cannula
Number of subjects: 0
Study: 32312273

Group type: EXPERIMENTAL
Intervention: Reactive hyperemia peripheral arterial tonometry (RH‐PAT)
Number of subjects: 157
Study: 36116147

Group type: COMPARATOR
Intervention: Acellular carbohydrate sources (e.g., flour‐based whole‐grain products)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Cellular carbohydrate sources (minimally processed foods with intact cellular structures such as fruits, potatoes/tubers, and rice)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate high-fat (LCHF) principles
Number of subjects: 193
Study: 34868475

Group type: EXPERIMENTAL
Intervention: EASE intervention (7 group sessions for children, 3 group sessions for caregivers)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Enhanced Treatment as Usual (ETAU)
Number of subjects: 59